Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Some neurosteroids have been shown to display beneficial effects on neuroprotection in rodents. To investigate the physiopathological significance of neurosteroids in Alzheimer’s disease (AD), we compared the concentrations of pregnenolone, pregnenolone sulfate (PREGS), dehydroepiandrosterone, dehydroepiandrosterone sulfate (DHEAS), progesterone, and allopregnanolone, measured by gas chromatography-mass spectrometry, in individual brain regions of AD patients and aged nondemented controls, including hippocampus, amygdala, frontal cortex, striatum, hypothalamus, and cerebellum. A general trend toward decreased levels of all steroids was observed in all AD patients’ brain regions compared with controls: PREGS and DHEAS were significantly lower in the striatum and cerebellum, and DHEAS was also significantly reduced in the hypothalamus. A significant negative correlation was found between the levels of cortical β-amyloid peptides and those of PREGS in the striatum and cerebellum and between the levels of phosphorylated tau proteins and DHEAS in the hypothalamus. This study provides reference values for steroid concentrations determined by gas chromatography-mass spectrometry in various regions of the aged human brain. High levels of key proteins implicated in the formation of plaques and neurofibrillary tangles were correlated with decreased brain levels of PREGS and DHEAS, suggesting a possible neuroprotective role of these neurosteroids in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Self-citationLabrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598
Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s2 · Cited by 519
Kimonides, V. G., Khatibi, N. H., Svendsen, C. N., Sofroniew, M. V., & Herbert, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1852 · Cited by 438
Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1989) · PubMed Central · Cited by 385
Neurosteroids: a new function in the brain
Baulieu, É. (1991) · Biology of the Cell · doi:10.1016/0248-4900(91)90045-o · Cited by 307
Research works printed but not linked: 1
- Goldman, 1991, Aging of the brain: dementia of the Alzheimer’s type, In: Kandel EK, ed. Principles of neural science, 3rd Ed. Amsterdam: Elsevier;, 974
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
New insights into brain BDNF function in normal aging and Alzheimer disease
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.007 · Cited by 571
Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70357-1 · Cited by 404
Sex and the development of Alzheimer's disease
Pike, C. J. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23827 · Cited by 402
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Steroid hormones and neurosteroids in normal and pathological aging of the nervous system
Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R. J. M., Garcia-Segura, L. M., Lambert, J. J., Mayo, W., Melcangi, R. C., Parducz, A., et al. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.004 · Cited by 300
Self-citationThe bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
Keitel, V., Görg, B., Bidmon, H. J., Zemtsova, I., Spomer, L., Zilles, K., & Häussinger, D. (2010) · Glia · doi:10.1002/glia.21049 · Cited by 274
“Altered neurosteroid levels have been implicated in the pathogenesis of neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease (di Michele et al., 2003; Weill-Engerer et al., 2002).”
BackgroundAllopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., & Brinton, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001422107 · Cited by 264
Diaz-Arrastia, R., Kochanek, P. M., Bergold, P., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, L. Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 262
Wang, J. M., Johnston, P. B., Ball, B. G., & Brinton, R. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4520-04.2005 · Cited by 261
Gonadal hormone modulation of hippocampal neurogenesis in the adult
Galea, L. A. M., Spritzer, M. D., Barker, J. M., & Pawluski, J. L. (2006) · Hippocampus · doi:10.1002/hipo.20154 · Cited by 238
“Allopregnanolone concentration in the brain of Alzheimer’s patients is diminished, suggesting that allopregnanolone may also play an important role in cognition and perhaps neuroplasticity (Weill-Engerer et al., 2002).”
BackgroundEstrogen, cognition and female ageing
Genazzani, A. R., Pluchino, N., Luisi, S., & Luisi, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dml042 · Cited by 237
Papadopoulos, V., Lecanu, L., Brown, R. C., Han, Z., & Yao, Z.-X. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.063 · Cited by 235
Schumacher, M., Guennoun, R., Robert, F., Carelli, C., Gago, N., Ghoumari, A., Gonzalez Deniselle, M. C., Gonzalez, S. L., Ibanez, C., Labombarda, F., et al. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.007 · Cited by 234
Self-citationCrews, L., Adame, A., Patrick, C., DeLaney, A., Pham, E., Rockenstein, E., Hansen, L., & Masliah, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1305-10.2010 · Cited by 222
“Interestingly, paralleling the decline in both the pool of NPCs and their proliferative potential in AD, the levels of various neurotrophic factors, including BDNF (brainderived neurotrophic factor), SCF (stem cell factor), and neurosteroids, among others, are dysregulated in AD and FAD-linked models (Weill-Engerer et…”
BackgroundProgesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair
Schumacher, M., Hussain, R., Gago, N., Oudinet, J.-P., Mattern, C., & Ghoumari, A. M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00010 · Cited by 217
Self-citationNeurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Neurosteroids as modulators of neurogenesis and neuronal survival
Charalampopoulos, I., Remboutsika, E., Margioris, A. N., & Gravanis, A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.004 · Cited by 202
Crewther, B. T., Cook, C., Cardinale, M., Weatherby, R. P., & Lowe, T. (2011) · Sports Medicine · doi:10.2165/11539170-000000000-00000 · Cited by 199
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Neuroprotective role of testosterone in the nervous system.
Białek, M., Zaremba, P., Borowicz, K. K., & Czuczwar, S. J. (2004) · PubMed · Cited by 192
DHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183
Luchetti, S., Huitinga, I., & Swaab, D. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.010 · Cited by 179
Sigma receptors [σRs]: biology in normal and diseased states
Rousseaux, C. G., & Greene, S. F. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1015737 · Cited by 169
Monnet, F. P., & Maurice, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050032 · Cited by 166
Marx, C. E., Stevens, R. D., Shampine, L. J., Uzunova, V., Trost, W. T., Butterfield, M. I., Massing, M. W., Hamer, R. M., Morrow, A. L., & Lieberman, J. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300952 · Cited by 165
“…to our knowledge have utilized mass spectrometry-based techniques to determine neuroactive steroid levels in human post-mortem brain tissue from subjects with Alzheimer’s disease (Weill-Engerer et al, 2002, 2003), the most highly sensitive and specific current methodology (Purdy et al, in press).”
MethodSchumacher, M., Guennoun, R., Ghoumari, A., Massaad, C., Robert, F., El-Etr, M., Akwa, Y., Rajkowski, K., & Baulieu, E.-E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0050 · Cited by 164
Self-citationZussy, C., Brureau, A., Delair, B., Marchal, S., Keller, E., IXART, G., Naert, G., Meunier, J., Chevallier, N., Maurice, T., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.021 · Cited by 162
Maurice, T., Gregoire, C. J., & Espallergues, J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.009 · Cited by 161
Sigwalt, A. R., Budde, H., Helmich, I., Glaser, V., Ghisoni, K., Lanza, S. R., Cadore, E. L., Lhullier, F. L. R., Bem, A. F. D., Hohl, A., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.075 · Cited by 164
Marx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., Strauss, J. L., & Kilts, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.076 · Cited by 160
The Neurosteroid Allopregnanolone Is Reduced in Prefrontal Cortex in Alzheimer’s Disease
Marx, C. E., Trost, W. T., Shampine, L. J., Stevens, R. D., Hulette, C. M., Steffens, D. C., Ervin, J. F., Butterfield, M. I., Blazer, D. G., Massing, M. W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.017 · Cited by 159
Neuroactive steroids: focus on human brain
Melcangi, R. C., Panzica, G., & García‐Segura, L. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.024 · Cited by 159
Caruso, D., Pesaresi, M., Abbiati, F., Calabrese, D., Giatti, S., García‐Segura, L. M., & Melcangi, R. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.04.016 · Cited by 157
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease
Pan, X., Elliott, C. T., McGuinness, B., Passmore, P., Kehoe, P. G., Hölscher, C., McClean, P. L., Graham, S. F., & Green, B. D. (2017) · Metabolites · doi:10.3390/metabo7020028 · Cited by 153
Adrenarche and the evolution of human life history
Campbell, B. (2006) · American Journal of Human Biology · doi:10.1002/ajhb.20528 · Cited by 150
Lee, Y. J., Kusuhara, H., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073320 · Cited by 140
Singh, C., Liu, L., Wang, J. M., Irwin, R. W., Yao, J., Chen, S., Henry, S., Thompson, R. F., & Brinton, R. D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.008 · Cited by 129
Lazaridis, I., Charalampopoulos, I., Alexaki, V.-I., Avlonitis, N., Pediaditakis, I., Efstathopoulos, P., Calogeropoulou, T., Castanas, E., & Gravanis, A. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001051 · Cited by 128
Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?
Ogundare, M., Theofilopoulos, S., Lockhart, A., Hall, L. J., Arenas, E., Sjövall, J., Brenton, A. G., Wang, Y., & Griffiths, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086678 · Cited by 128
Gaignard, P., Liere, P., Thérond, P., Schumacher, M., Slama, A., & Guennoun, R. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00406 · Cited by 128
Self-citationNeurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease
Luchetti, S., Bossers, K., de Bilt, S. V., Agrapart, V., Morales, R., Frajese, G. V., & Swaab, D. F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.014 · Cited by 127
Yau, J. L. W., Rasmuson, S., Andrew, R., Graham, M., Noble, J., Olsson, T., Fuchs, E., Lathe, R., & Seckl, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00438-x · Cited by 125
Neurosteroids and potential therapeutics: Focus on pregnenolone
Vallée, M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.030 · Cited by 123
Pesaresi, M., Maschi, O., Giatti, S., García‐Segura, L. M., Caruso, D., & Melcangi, R. C. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.04.008 · Cited by 120
Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Liu, S., Griffiths, W., Schumacher, M., Sjövall, J., & Baulieu, E.-E. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400244-jlr200 · Cited by 118
Self-citationPregnenolone sulfate in the brain: A controversial neurosteroid
Schumacher, M., Lière, P., Akwa, Y., Rajkowski, K. M., Griffiths, W. J., Bodin, K., Sjövall, J., & Baulieu, É.-É. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.08.022 · Cited by 115
Self-citationNeuroprotective Actions of Neurosteroids
Borowicz, K. K., Piskorska, B., Banach, M., & Czuczwar, S. J. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00050 · Cited by 115
Diaz Brinton, R., & Ming Wang, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506777632817 · Cited by 113
Neurosteroids as Endogenous Inhibitors of Neuronal Cell Apoptosis in Aging
CHARALAMPOPOULOS, I., ALEXAKI, V., TSATSANIS, C., MINAS, V., DERMITZAKI, E., LASARIDIS, I., VARDOULI, L., STOURNARAS, C., MARGIORIS, A. N., CASTANAS, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.003 · Cited by 111
Regenerative potential of allopregnanolone
Wang, J. M., Liu, L., Irwin, R. W., Chen, S., & Brinton, R. D. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.08.010 · Cited by 110
Steroid profiling in pregnancy: A focus on the human fetus
Hill, M., Pašková, A., Kančeva, R., Velíková, M., Kubátová, J., Kancheva, L., Adamcová, K., Mikešová, M., Žižka, Z., Koucký, M., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.03.008 · Cited by 110
Ishunina, T. A., van Beurden, D., van der Meulen, G., Unmehopa, U. A., Hol, E. M., Huitinga, I., & Swaab, D. F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.010 · Cited by 109
Neurosteroids and GABAA Receptor Interactions: A Focus on Stress
Gunn, B. G., Brown, A. R., Lambert, J. J., & Belelli, D. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00131 · Cited by 108
DHEAS as a new diagnostic tool
Leowattana, W. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.031 · Cited by 106
Disease-Modifying Therapies in Alzheimer???s Disease: How Far Have We Come?
ll, M. H., Berger, T., & Heneka, M. T. (2006) · Drugs · doi:10.2165/00003495-200666160-00004 · Cited by 107
Irwin, R. W., & Brinton, R. D. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.004 · Cited by 106
Insights into Disease-Associated Tau Impact on Mitochondria
Szabo, L., Eckert, A., & Grimm, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176344 · Cited by 105
The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside
Strous, R. D., Maayan, R., & Weizman, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.005 · Cited by 106
Li, L., Xu, B., Zhu, Y., Chen, L., Sokabe, M., & Chen, L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.009 · Cited by 104
Endogenous neuroprotective factors: neurosteroids.
Wojtal, K., Trojnar, M. K., & Czuczwar, S. J. (2006) · PubMed · Cited by 103
Brain microglia express steroid-converting enzymes in the mouse
Gottfried‐Blackmore, A., Sierra, A., Jellinck, P. H., McEwen, B. S., & Bulloch, K. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.12.013 · Cited by 101
Separation of steroid isomers by ion mobility mass spectrometry
Ahonen, L. L., Fasciotti, M., af Gennäs, G. B., Kotiaho, T., Daroda, R. J., Eberlin, M. N., & Kostiainen, R. K. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.08.056 · Cited by 101
Neuroactive steroids and peripheral neuropathy
Roglio, I., Giatti, S., Pesaresi, M., Bianchi, R., Cavaletti, G., Lauria, G., García‐Segura, L. M., & Melcangi, R. C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.010 · Cited by 101
Bortfeld, M., Rius, M., König, J., Herold‐Mende, C. C., Nies, A. T., & KEPPLER, D. O. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.025 · Cited by 99
Charalampopoulos, I., Dermitzaki, E., Vardouli, L., Tsatsanis, C., Stournaras, C., Margioris, A. N., & Gravanis, A. (2005) · Endocrinology · doi:10.1210/en.2005-0263 · Cited by 98
Naylor, J. C., Kilts, J. D., Hulette, C. M., Steffens, D. C., Blazer, D. G., Ervin, J. F., Strauss, J. L., Allen, T. B., Massing, M. W., & Payne, V. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.006 · Cited by 98
Neurosteroids: Cerebrospinal Fluid Levels for Alzheimer’s Disease and Vascular Dementia Diagnostics
Kim, S.-B., Hill, M., Kwak, Y.-T., Hampl, R., Jo, D.-H., & Morfin, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030646 · Cited by 97
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
Ratner, M. H., Kumaresan, V., & Farb, D. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00169 · Cited by 96
Weill‐Engerer, S., David, J.-P., Sazdovitch, V., Lière, P., Schumacher, M., Delacourte, A., Baulieu, É.-É., & Akwa, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02288-1 · Cited by 95
Self-citationNeurosteroid Transport in the Brain: Role of ABC and SLC Transporters
Grube, M., Hagen, P., & Jedlitschky, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00354 · Cited by 92
Pregnenolone sulfate: from steroid metabolite to TRP channel ligand
Harteneck, C. (2013) · Molecules · doi:10.3390/molecules181012012 · Cited by 89
Neurosteroids’ effects and mechanisms for social, cognitive, emotional, and physical functions
Frye, C. A. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.07.005 · Cited by 88
Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 87
Neurobiology of DHEA and effects on sexuality, mood and cognition
Pluchino, N., Drakopoulos, P., Bianchi‐Demicheli, F., Wenger, J. M., Petignat, P., & Genazzani, A. R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.012 · Cited by 85
Xie, G., Wang, X., Jiang, R., Zhao, A., Yan, J., Zheng, X., Huang, F., Liu, X., Panee, J., Rajani, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.030 · Cited by 84
Marx, C. E., Shampine, L. J., Duncan, G. E., VanDoren, M. J., Grobin, A. C., Massing, M. W., Madison, R. D., Bradford, D. W., Butterfield, M. I., Lieberman, J. A., et al. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.026 · Cited by 84
Steckelbroeck, S., Nassen, A., Ugele, B., Ludwig, M., Watzka, M., Reissinger, A., Clusmann, H., Lütjohann, D., Siekmann, L., Klingmüller, D., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02336.x · Cited by 83
Irwin, R. W., Solinsky, C. M., & Brinton, R. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00203 · Cited by 82
Dehydroepiandrosterone: Is There a Role for Replacement?
Dhatariya, K., & Nair, K. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.10.1257 · Cited by 79
Anti‐apoptotic effects of allopregnanolone on P19 neurons
Xilouri, M., & Papazafiri, P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04548.x · Cited by 78
Charalampopoulos, I., Alexaki, V., Lazaridis, I., Dermitzaki, E., Avlonitis, N., Tsatsanis, C., Calogeropoulou, T., Margioris, A. N., Castanas, E., & Gravanis, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5078fje · Cited by 77
Dehydroepiandrosterone and age-related cognitive decline
Sorwell, K. G., & Urbanski, H. F. (2009) · AGE · doi:10.1007/s11357-009-9113-4 · Cited by 74
Yang, R., Chen, L., Wang, H., Xu, B., Tomimoto, H., & Chen, L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.035 · Cited by 73
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Marx, C. E., Lee, J., Subramaniam, M., Rapisarda, A., Bautista, D., Chan, E. S., Kilts, J. D., Buchanan, R. W., Eu, P. W., Verma, S. K., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3673-4 · Cited by 73
Kořínek, M., Kapras, V., Vyklický, V., Adamusová, E., Borovská, J., Valeš, K., Stuchlík, A., Hořák, M., Chodounská, H., & Vyklický, L. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.002 · Cited by 72
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients
Caruso, D., Melis, M., Fenu, G., Giatti, S., Romano, S., Grimoldi, M. G., Crippa, D., Marrosu, M. G., Cavaletti, G., & Melcangi, R. C. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12745 · Cited by 72
Aldred, S., & Mecocci, P. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.07.001 · Cited by 69
Reversal of propoxur-induced impairment of memory and oxidative stress by 4′-chlorodiazepam in rats
Mehta, K. D., Garg, G. R., Mehta, A. K., Arora, T., Sharma, A. K., Khanna, N., Tripathi, A. K., & Sharma, K. K. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0475-z · Cited by 68
The Brain Metabolome of Male Rats across the Lifespan
Zheng, X., Chen, T., Zhao, A., Wang, X., Xie, G., Huang, F., Liu, J., Zhao, Q., Wang, S., Wang, C., et al. (2016) · Scientific Reports · doi:10.1038/srep24125 · Cited by 67
Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice
Wong, P., Chang, C. C. R., Marx, C. E., Caron, M. G., Wetsel, W. C., & Zhang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051455 · Cited by 65
Milestones on Steroids and the Nervous System: 10 Years of Basic and Translational Research
Panzica, G., Balthazart, J., Frye, C. A., García‐Segura, L. M., Herbison, A. E., Mensah‐Nyagan, A. G., McCarthy, M. M., & Melcangi, R. C. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02265.x · Cited by 64
Dehydroepiandrosterone Sulphate: Action and Mechanism in the Brain
Dong, Y. W., & Zheng, P. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02256.x · Cited by 63
Steroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential
Akwa, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134812 · Cited by 62
Self-citationRegeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Wang, J., Irwin, R. W., Liu, L., Chen, S., & Brinton, R. D. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018262 · Cited by 62
Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases
Schverer, M., Lanfumey, L., Baulieu, É.-É., Froger, N., & Villey, I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.011 · Cited by 62
Ahboucha, S., Pomier–Layrargues, G., Mamer, O., & Butterworth, R. F. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.02.002 · Cited by 62
Metadata
- Authors
- Weill-Engerer, S., David, J.-P., Sazdovitch, V., Liere, P., Eychenne, B., Pianos, A., Schumacher, M., Delacourte, A., Baulieu, E.-E., & Akwa, Y.
- Affiliations
- INSERM, U-488 (S.W.E., P.L., B.E., A.P., M.S., E.E.B., Y.A.), 54276 Le Kremlin-Bicêtre, France;
- Inserm (FR)
- Assistance Publique-Hôpitaux de Paris, Service d’Anatomie Pathologique Neurologique, Hôpital Pitié-Salpêtrière (V.S.), 75013 Paris, France
- INSERM, U-422 (J.P.D., A.D.), 59045 Lille, France;
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-11-01
- Volume
- 87
- Issue
- 11
- Pages
- 5138-5143
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2066385861
- Cited by
- 333
- References
- 43
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 9 · 2016: 15 · 2015: 16 · 2014: 15 · 2013: 17 · 2012: 16
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurosteroids, Alzheimer's disease, pregnenolone sulfate, dehydroepiandrosterone sulfate, dehydroepiandrosterone, pregnenolone, progesterone, allopregnanolone, brain regions, amyloid-beta, phosphorylated tau, neuroprotection, brain aging, reference values, striatum, cerebellum, hypothalamus
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Amygdala, Brain Chemistry, Cerebellum, Corpus Striatum, Female, Frontal Lobe, Hippocampus, Humans, Hypothalamus, Male, Gas Chromatography-Mass Spectrometry, Pregnanolone, Pregnenolone, Progesterone, Steroids, Amyloid beta-Peptides, tau Proteins, Protein Structure, Secondary, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.